Structure Therapeutics Inc. Sponsored ADR (GPCR)
(Delayed Data from NSDQ)
$54.29 USD
+1.55 (2.94%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $54.50 +0.21 (0.39%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
GPCR 54.29 +1.55(2.94%)
Will GPCR be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for GPCR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GPCR
Structure Therapeutics (GPCR) Stock Up 9% This Week: Here's Why
IPO Round Up of First Half of 2023
GPCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GPCR
Qiming's Nisa Leung Made the 2024 Forbes Midas List
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Analysts’ Top Healthcare Picks: Formycon AG (DE:FYB), Novartis AG (CH:NOVN)
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
10 Health Care Stocks With Whale Alerts In Today's Session